Press Releases Investor Menu Overview Press Releases Events & Presentations Events Presentations Stock Information Stock Quote & Chart Analyst Coverage Historic Price Lookup Financials Quarterly Results Annual Reports SEC Filings Governance Governance Highlights Leadership Board of Directors Committee Composition Investor Resources Investor FAQs Investor Email Alerts Investor Contact Year None20262025202420232022 August 18, 2026 Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference August 13, 2026 Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update July 27, 2026 Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026 June 16, 2026 Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 10, 2026 Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™ June 3, 2026 Quantum-Si Announces the Expansion of the Proteus™ Roadshow May 13, 2026 Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 7, 2026 Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones May 1, 2026 Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ April 28, 2026 Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments Current page 1 Page 2 Page 3 Last Next Displaying 1 - 10 of 21 Print Page Email Alerts RSS Feeds Contact IR
Year None20262025202420232022 August 18, 2026 Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference August 13, 2026 Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update July 27, 2026 Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026 June 16, 2026 Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 10, 2026 Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™ June 3, 2026 Quantum-Si Announces the Expansion of the Proteus™ Roadshow May 13, 2026 Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 7, 2026 Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones May 1, 2026 Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ April 28, 2026 Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments Current page 1 Page 2 Page 3 Last Next Displaying 1 - 10 of 21
